Literature DB >> 1954670

Active downregulation of myocardial energy requirements during prolonged moderate ischemia in swine.

A E Arai1, G A Pantely, C G Anselone, J Bristow, J D Bristow.   

Abstract

We studied the effects of rapid atrial pacing during the final 10 minutes of a 70-minute, 31% reduction in coronary blood flow in anesthetized swine to understand the significance of apparent metabolic improvements during the initial 60 minutes of segmental ischemia. Within 5-10 minutes of ischemia, subendocardial phosphocreatine (PCr) and ATP were depleted to 47% and 63% of control, respectively; lactate accumulated within the subendocardium to 300% of control; and net arteriovenous lactate production occurred. Despite continued ischemia and no significant changes in the external determinants of myocardial oxygen consumption, by 60 minutes subendocardial PCr and lactate contents returned to near control levels and there was net arteriovenous lactate consumption. Ischemic left ventricular wall thickening and ATP levels remained depressed throughout the experiment. Atrial pacing during the final 10 minutes of ischemia again resulted in depletion of PCr and lactate production. Since the myocardium was capable of hydrolyzing PCr in response to atrial pacing at 60 minutes of ischemia, we conclude it was capable of hydrolyzing PCr during the period of constant ischemia when instead it was accumulating PCr. We propose the ischemic myocardium downregulates regional energy requirements below blood flow-limited rates of energy production during ischemia. This appears to be an active adaptation to ischemia and not a result of passive damage or cellular injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954670     DOI: 10.1161/01.res.69.6.1458

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

Review 1.  The relation of contractile function to myocardial perfusion. Perfusion-contraction match and mismatch.

Authors:  G Heusch; R Schulz
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

Review 2.  Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

Authors:  J L Vanoverschelde; A Pasquet; B Gerber; J A Melin
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 3.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

4.  Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.

Authors:  P H McNulty; A J Sinusas; C Q Shi; D Dione; L H Young; G C Cline; G I Shulman
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 5.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

6.  Controversies in cardiovascular MR imaging: reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction.

Authors:  Andrew E Arai; Steve Leung; Peter Kellman
Journal:  Radiology       Date:  2012-10       Impact factor: 11.105

Review 7.  Hypoxia. 2. Hypoxia regulates cellular metabolism.

Authors:  William W Wheaton; Navdeep S Chandel
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

Review 8.  Hibernating myocardium: a hypometabolic state for energy conservation.

Authors:  G A Pantely; J D Bristow
Journal:  Basic Res Cardiol       Date:  1995 Jan-Feb       Impact factor: 17.165

Review 9.  Contractile pattern in acutely hibernating myocardium.

Authors:  A Ilebekk; J Offstad; K Lande; K A Kirkebøen
Journal:  Basic Res Cardiol       Date:  1995 Jan-Feb       Impact factor: 17.165

10.  Decreased interstitial glucose and transmural gradient in lactate during ischemia.

Authors:  J L Hall; L A Hernandez; J Henderson; L A Kellerman; W C Stanley
Journal:  Basic Res Cardiol       Date:  1994 Sep-Oct       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.